InfuSystem to Participate in Lake Street’s 7th Annual Best Ideas Growth (BIG7) Conference September 14, 2023
September 05 2023 - 5:30AM
Business Wire
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or
the “Company”), a leading national health care service provider,
facilitating outpatient care for durable medical equipment
manufacturers and health care providers, announced today that
Richard DiIorio, Chief Executive Officer, Barry Steele, Chief
Financial Officer, and Carrie Lachance, President and Chief
Operating Officer will participate in Lake Street Capital Markets’
7th Annual Best Ideas Growth (BIG7) Conference on Thursday,
September 14, 2023. The conference is being held at The Yale Club
in New York City.
Management will be available for one-on-one and group meetings
with investors throughout the day. To receive additional
information, request an invitation or to schedule a one-on-one
meeting, please email conference@lakestreetcm.com. Conversely, you may
also call or email Lytham Partners at 602-889-9700, or infu@lythampartners.com.
About the BIG7 Conference
Lake Street will host its 7th Annual Best Ideas Growth (BIG7)
Conference at The Yale Club in New York. BIG is our annual
signature event, featuring dynamic public companies across multiple
sectors, paired with world-class institutional investors, in a
one-on-one meeting format. This is an invitation-only event
attended by top institutional investors from across the
country.
For more information, visit https://www.lakestreetcapitalmarkets.com/big7conference
or contact your Lake Street representative, email conference@lakestreetcm.com or call
612-326-1305.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading
national health care service provider, facilitating outpatient care
for durable medical equipment manufacturers and health care
providers. INFU services are provided under a two-platform model.
The lead platform is Patient Services (formerly Integrated Therapy
Services, or ITS), providing the last-mile solution for
clinic-to-home healthcare where the continuing treatment involves
complex durable medical equipment and services. The Patient
Services segment is comprised of Oncology, Pain Management, Wound
Therapy and Lymphedema businesses. The second platform, Device
Solutions (formerly Durable Medical Equipment Services, or DME
Services), supports the Patient Services platform and leverages
strong service orientation to win incremental business from its
direct payer clients. The Device Solutions segment is comprised of
direct payer rentals, pump and consumable sales, and biomedical
services and repair. Headquartered in Rochester Hills, Michigan,
the Company delivers local, field-based customer support and also
operates Centers of Excellence in Michigan, Kansas, California,
Massachusetts, Texas and Ontario, Canada.
Forward-Looking Statements
Certain statements contained in this press release are
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, such as statements
relating to future actions, our share repurchase program and
capital allocation strategy, business plans, growth initiatives,
objectives and prospects, future operating or financial
performance, guidance and expected new business relationships and
the terms thereof (including estimated potential revenue under new
or existing contracts). The words “believe,” “may,” “will,”
“estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,”
“expect,” “strategy,” “future,” “likely,” variations of such words,
and other similar expressions, as they relate to the Company, are
intended to identify forward-looking statements. Forward-looking
statements are subject to factors, risks and uncertainties that
could cause actual results to differ materially, including, but not
limited to, our ability to successfully execute on our growth
initiatives, our ability to enter into definitive agreements for
new business relationships on expected terms or at all, our ability
to generate estimated potential revenue amounts under new or
existing contracts, the uncertain impact of the COVID-19 pandemic,
our dependence on estimates of collectible revenue, potential
litigation, changes in third-party reimbursement processes, changes
in law, supply chain disruptions, contributions from acquired
businesses or new business lines, products or services and other
risk factors disclosed in the Company’s most recent annual report
on Form 10-K and, to the extent applicable, quarterly reports on
Form 10-Q. All forward-looking statements made in this press
release speak only as of the date hereof. We do not undertake any
obligation to update any forward-looking statements to reflect
future events or circumstances, except as required by law.
Additional information about InfuSystem Holdings, Inc. is
available at www.infusystem.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230905007881/en/
Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC
602-889-9700
InfuSystems (AMEX:INFU)
Historical Stock Chart
From Aug 2024 to Sep 2024
InfuSystems (AMEX:INFU)
Historical Stock Chart
From Sep 2023 to Sep 2024